Epistemix
United States
- Pittsburgh, Pennsylvania
- 01/03/2022
- Seed
- $5,000,000
Epistemix is a leading provider of analytical tools that empower leaders to make better decisions by simulating how diseases, ideas, and behavior spread through communities. We leverage decades of epidemiological experience, diverse datasets, realistic population dynamics, and scientific best-practice to build computational models that forecast the human impacts of policy interventions, so that organizations can take informed action. Our simulations have been used by groups like the Centers for Disease Control, the National Institutes of Health, and the World Health Organization. We are currently working with companies, event organizers, schools, and state and local governments across the United States to evaluate opening strategies and gauge COVID-19 response.
- Industry Software Development
- Website https://www.epistemix.com/
- LinkedIn https://www.linkedin.com/company/epistemix/
Related People
John CordierCo Founder
United States -
Pittsburgh, Pennsylvania
Working to improve conditions for people to live better lives.
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)